• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫组织化学双重染色作为评估黑色素瘤有丝分裂活性的辅助方法。

Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.

作者信息

Ikenberg Kristian, Pfaltz Madeleine, Rakozy Christiane, Kempf Werner

机构信息

Kempf and Pfaltz Histological Diagnostics, Zurich, Switzerland.

出版信息

J Cutan Pathol. 2012 Mar;39(3):324-30. doi: 10.1111/j.1600-0560.2011.01858.x.

DOI:10.1111/j.1600-0560.2011.01858.x
PMID:22335591
Abstract

BACKGROUND

The mitotic rate was introduced as a major prognostic criterion for the staging of thin (≤1.0 mm) melanoma by the 2009 American Joint Committee on Cancer Staging and Classification (seventh edition). The detection of a single mitotic figure changes the tumor stage in thin melanoma. We sought to address the value of a dual staining to facilitate the determination of the mitotic rate and to assign the mitotic activity to melanocytes.

METHODS

The mitotic rate of melanoma cells was determined by dual phosphohistone-H3 (PHH3)/Melan-A immunohistochemistry. Results were compared with PHH3 staining alone and conventional hematoxylin and eosin (H&E)-stained slides of 15 melanomas with a tumor thickness <1.0 mm.

RESULTS

PHH3 staining clearly labeled cells in the mitotic cell cycle. The mitotic rate in the PHH3/Melan-A dual stain was equal to that derived by H&E staining. Time required for counting mitotic figures was significantly reduced.

CONCLUSIONS

The evaluation of mitotic rate with an immunohistochemical dual stain is faster (mean 63.0%) and more reliable than evaluation by routine H&E staining alone. Dual staining immunohistochemistry may be a useful additional tool to standardize the determination of mitotic rate and may be helpful in evaluation of challenging cases.

摘要

背景

有丝分裂率被2009年美国癌症联合委员会分期与分类(第七版)作为薄型(≤1.0 mm)黑色素瘤分期的主要预后标准引入。检测到单个有丝分裂象会改变薄型黑色素瘤的肿瘤分期。我们试图探讨双重染色在促进有丝分裂率测定以及将有丝分裂活性归因于黑素细胞方面的价值。

方法

通过磷酸化组蛋白H3(PHH3)/黑素A双重免疫组织化学法测定黑色素瘤细胞的有丝分裂率。将结果与单独的PHH3染色以及15例肿瘤厚度<1.0 mm的黑色素瘤的传统苏木精和伊红(H&E)染色切片进行比较。

结果

PHH3染色清晰地标记了处于有丝分裂细胞周期的细胞。PHH3/黑素A双重染色中的有丝分裂率与H&E染色得出的结果相等。计数有丝分裂象所需的时间显著减少。

结论

与单独的常规H&E染色相比,采用免疫组织化学双重染色评估有丝分裂率更快(平均快63.0%)且更可靠。双重染色免疫组织化学可能是一种有用的辅助工具,可使有丝分裂率的测定标准化,并且可能有助于评估具有挑战性的病例。

相似文献

1
Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.免疫组织化学双重染色作为评估黑色素瘤有丝分裂活性的辅助方法。
J Cutan Pathol. 2012 Mar;39(3):324-30. doi: 10.1111/j.1600-0560.2011.01858.x.
2
Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.使用抗磷酸化组蛋白H3免疫组织化学方法测定薄型黑色素瘤的有丝分裂率。
Am J Dermatopathol. 2010 Oct;32(7):650-4. doi: 10.1097/DAD.0b013e3181cf7cc1.
3
Detection of mitotic figures in thin melanomas--immunohistochemistry does not replace the careful search for mitotic figures in hematoxylin-eosin stain.在薄型黑色素瘤中检测有丝分裂象——免疫组化不能替代在苏木精-伊红染色中仔细寻找有丝分裂象。
J Am Acad Dermatol. 2015 Oct;73(4):637-44. doi: 10.1016/j.jaad.2015.07.007. Epub 2015 Aug 13.
4
pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.pHH3免疫染色可提高薄型黑色素瘤有丝分裂指数的观察者间一致性。
Am J Dermatopathol. 2012 May;34(3):266-9. doi: 10.1097/DAD.0b013e31823135a3.
5
Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanoma.有丝分裂标志物磷酸组蛋白 H3 在皮肤结节性黑素瘤中的预后意义。
J Invest Dermatol. 2012 Apr;132(4):1247-52. doi: 10.1038/jid.2011.464. Epub 2012 Feb 2.
6
Differences in tumor thickness between hematoxylin and eosin and Melan-A immunohistochemically stained primary cutaneous melanomas.苏木精和伊红染色与Melan-A免疫组化染色的原发性皮肤黑色素瘤之间肿瘤厚度的差异。
Am J Dermatopathol. 2013 Feb;35(1):56-63. doi: 10.1097/DAD.0b013e31825ba933.
7
Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.抗磷酸化组蛋白H3抗体免疫染色在脑膜瘤病例有丝分裂计数中的敏感性和实用性。
Brain Tumor Pathol. 2009;26(2):51-7. doi: 10.1007/s10014-009-0249-9. Epub 2009 Oct 27.
8
Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.磷酸组蛋白 H3 免疫组化染色的有丝分裂计数可预测生存并提高胰腺高分化神经内分泌肿瘤的观察者间可重复性。
Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.
9
Immunohistochemical assessment of mitotic count in uveal melanoma.葡萄膜黑色素瘤有丝分裂计数的免疫组织化学评估。
Acta Ophthalmol. 2011 Mar;89(2):e155-60. doi: 10.1111/j.1755-3768.2009.01769.x.
10
Frequent mitotic activity in banal melanocytic nevi uncovered by immunohistochemical analysis.免疫组织化学分析揭示普通黑素细胞痣中频繁的有丝分裂活性。
Am J Dermatopathol. 2010 Oct;32(7):643-9. doi: 10.1097/DAD.0b013e3181d7ce6f.

引用本文的文献

1
Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.利用磷酸化组蛋白 H3(PHH3)抗体与苏木精和伊红复染,提高有丝分裂细胞计数的准确性和效率,作为乳腺癌分级的一部分。
Histopathology. 2023 Feb;82(3):393-406. doi: 10.1111/his.14837. Epub 2022 Nov 18.
2
Mammary Paget Disease With Melanocytic Proliferation Mimicking Malignant Melanoma : A Case Report.伴有黑素细胞增生酷似恶性黑色素瘤的乳腺佩吉特病:一例报告
Front Med (Lausanne). 2022 Mar 21;9:839954. doi: 10.3389/fmed.2022.839954. eCollection 2022.
3
Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade.
PHH3在评估乳腺癌有丝分裂指数中的应用及其对肿瘤分级的影响。
Asian Pac J Cancer Prev. 2020 Jan 1;21(1):63-66. doi: 10.31557/APJCP.2020.21.1.63.
4
Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis.显微镜检查与数字全切片图像在有丝分裂活性组织学评估中的一致性为临床诊断的转换提供依据。
Acad Pathol. 2019 Jul 11;6:2374289519859841. doi: 10.1177/2374289519859841. eCollection 2019 Jan-Dec.
5
Dual Immunohistochemical Detection of Mitoses in Melanoma.黑色素瘤有丝分裂的双重免疫组织化学检测
Pathol Oncol Res. 2018 Jan;24(1):179-183. doi: 10.1007/s12253-017-0203-9. Epub 2017 Feb 12.
6
Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.在磷酸化组蛋白H3/MART1双重染色的I/II期黑色素瘤中通过自动热点选择对增殖进行自动定量分析。
Diagn Pathol. 2016 Apr 9;11:35. doi: 10.1186/s13000-016-0484-4.
7
Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.皮肤肿瘤的诊断性免疫组织化学:最新进展
Dermatopathology (Basel). 2015 Apr 8;2(1):15-42. doi: 10.1159/000377698. eCollection 2015 Jan-Mar.
8
Emerging clinical applications of selected biomarkers in melanoma.特定生物标志物在黑色素瘤中的新兴临床应用
Clin Cosmet Investig Dermatol. 2015 Jan 30;8:35-46. doi: 10.2147/CCID.S49578. eCollection 2015.
9
Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.看得更仔细才能更好地达成一致:磷酸化组蛋白H3提高了脑膜瘤分级中有丝分裂计数的观察者间一致性,并设定了新的特定阈值。
Neuro Oncol. 2015 May;17(5):663-9. doi: 10.1093/neuonc/nov002. Epub 2015 Feb 1.
10
Variability in mitotic figures in serial sections of thin melanomas.薄型黑色素瘤连续切片中分裂象的变异性。
J Am Acad Dermatol. 2014 Dec;71(6):1204-11. doi: 10.1016/j.jaad.2014.07.056. Epub 2014 Sep 16.